Literature DB >> 7678264

Polarized secretion of IGF-I and IGF-I binding protein activity by cultured aortic endothelial cells.

W R Taylor1, R M Nerem, R W Alexander.   

Abstract

Insulin-like growth factor-I (IGF-I) secretion by the vascular endothelium has been proposed to play a role in the regulation of vascular smooth muscle cell proliferation. Because vascular smooth muscle cells are adjacent to the abluminal surface of the endothelium, we tested the hypothesis that secretion of IGF-I by endothelial cells is polarized. Porcine aortic endothelial cells were cultured on permeable membranes and IGF-I measured by radioimmunoassay. Basal secretion exceeded apical secretion by a ratio of 2.3 +/- 0.2:1.0 (P < 0.05). We also identified 35 kDa IGF-I binding protein activity that is preferentially secreted on the basal surface of endothelial cells. We conclude that both IGF-I and IGF-I binding protein activity secretion by endothelial cells is polarized towards the basal surface of the endothelium. A polarized secretion mechanism for IGF-I may be of importance in the normal growth and differentiation of the vasculature as well as in the development of vascular pathology.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7678264     DOI: 10.1002/jcp.1041540117

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  2 in total

1.  IGF binding protein-6 expression in vascular endothelial cells is induced by hypoxia and plays a negative role in tumor angiogenesis.

Authors:  Chunyang Zhang; Ling Lu; Yun Li; Xianlei Wang; Jianfeng Zhou; Yunzhang Liu; Ping Fu; Marisa A Gallicchio; Leon A Bach; Cunming Duan
Journal:  Int J Cancer       Date:  2011-08-05       Impact factor: 7.396

Review 2.  Diabetic microangiopathy: IGFBP control endothelial cell growth by a common mechanism in spite of their species specificity and tissue peculiarity.

Authors:  S Giannini; B Cresci; C Manuelli; L Pala; C M Rotella
Journal:  J Endocrinol Invest       Date:  2006-09       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.